Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
C21 Investments Inc. (CXXIF)
Standardized SEC financial data for C21 Investments Inc. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0000831609 · OTC · Medicinal Chemicals & Botanical Products.
Income statement
USD
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
$37.7M
$36.1M
$33.0M
$28.9M
$28.3M
$30.1M
Cost of revenue
$25.8M
$19.1M
$14.2M
$15.5M
$17.1M
$17.6M
Gross profit
$13.1M
$18.0M
$18.8M
$13.4M
$11.1M
$12.6M
SG&A expense
$9.3M
$8.8M
$9.1M
$9.4M
$9.7M
$11.3M
Operating income
—
$9.2M
$9.8M
$4.0M
$1.5M
$1.3M
EBITDA
—
$11.5M
$11.6M
$5.8M
$2.9M
$3.0M
Interest expense
$3.9M
$3.9M
$2.3M
$506K
$52K
$294K
Pretax income
—
-$1.6M
$17.1M
$4.2M
$259K
$395K
Income tax
—
$3.0M
$4.9M
$2.8M
$3.5M
$4.2M
Net income
—
-$7.8M
$10.0M
$293K
-$3.3M
-$4.0M
EPS (diluted)
—
$-0.07
$0.08
$0.00
$-0.03
$-0.03
Standardized from C21 Investments Inc.'s SEC filings — per-share figures split-adjusted. Full history via the API.